Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus

Detroit, Michigan 48201-2013

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Hepatocellular, Relapsed/Refractory Multiple Myeloma

Studies at this site

• A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma — Completed
• Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma — Stopped early